"Even in this time of uncertainty, Mayo Clinic is a place for hope and healing — and we're delivering the care you need. Mayo Clinic follows carefully designed, rigorously enforced safety precautions for anyone who needs face-to-face care. We're safely treating all patients, both in person and through virtual visits, in adherence with federal and state executive orders and guidance. Mayo Clinic provides expert care to everyone who needs healing. That means combining our comprehensive, integrated care with a seamless patient experience to provide exactly the care you need. Mayo Clinic Hospital, Methodist Campus, is located in downtown Rochester. It has 794 licensed beds and 37 operating rooms."

During the past decade, Rochester Methodist Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rochester Methodist Hospital" #1 sponsor was "National Heart, Lung, and Blood Institute (NHLBI)" with 5 trials, followed by "Tsumura USA" with 3 trials sponsored, "Pfizer" with 2 trials sponsored, "Biotest Pharmaceuticals Corporation" with 1 trials sponsored and "HI-Bio" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rochester Methodist Hospital" #1 collaborator was "Cato Research" with 3 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Rochester Methodist Hospital" are "Respiratory Distress Syndrome, Adult" (3 trials), "Abdominal Pain" (1 trials), "Acute Lung Injury" (1 trials), "Cardiovascular Diseases" (1 trials) and "Clostridium Difficile Infection" (1 trials). Many other conditions were trialed in "Rochester Methodist Hospital" in a lesser frequency.

Most popular intervention types in "Rochester Methodist Hospital" are "Drug" (6 trials), "Biological" (3 trials), "Behavioral" (2 trials), "Other" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Daikenchuto (TU-100)" (3 trials), "Full Feeding" (2 trials), "Minimal (Trophic) Feeding" (2 trials) and "Albuterol Sulfate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rochester Methodist Hospital" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Rochester Methodist Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Rochester Methodist Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Rochester Methodist Hospital, 4 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".